SCHEMBL18464720

SCHEMBL18464720

Fc1ccc(-c2c(CBr)ncc3ccccc23)cc1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 2/20 0.37
▸ CYP11B2 P19099 2/20 0.37
▸ CYP1A2 P05177 2/20 0.36
▸ CYP1A1 P04798 1/20 0.36
▸ CYP1B1 Q16678 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ ERN1 O75460 1/20 0.34
▸ GRM5 P41594 1/20 0.34
▸ GPR3 P46089 1/20 0.34
▸ TOP1 P11387 1/20 0.34
▸ ALOX5 P09917 1/20 0.33
▸ PIK3CA P42336 1/20 0.33
▸ GPR68 Q15743 1/20 0.33
▸ PDGFRB P09619 1/20 0.33
▸ PDGFRA P16234 1/20 0.33
▸ ALOX5AP P20292 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18464716 0.85 CYP1A2 (0.43) CYP1A2HTTKDM4EALDH1A1GPR3
SCHEMBL18464723 0.84 TDP1 (0.48) CYP1A2HTTKDM4EGRM5GPR3
SCHEMBL18425832 0.83 DHODH (0.40) CYP1A2HTTKDM4EGRM5GPR3
SCHEMBL18464728 0.79 TACR1 (0.39) TOP1TDP1MAPTL3MBTL1
SCHEMBL28255145 0.77 CYP1B1 (0.43) CYP1A2CYP1A1CYP1B1ALDH1A1ALOX5
SCHEMBL18464722 0.76 EGFR (0.40) CYP11B1CYP11B2
SCHEMBL18464633 0.76 GPR84 (0.39) HTTKDM4ERAB9AGPR3NPC1
SCHEMBL18464729 0.74 CHEK1 (0.37) CYP11B1CYP11B2KDM4EGPR3
SCHEMBL19915597 0.73 KDM4E (0.33) CYP11B1CYP11B2KDM4EGPR3ALOX5AP
SCHEMBL18425748 0.72 PIK3CD (0.37) KDM4EGPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3328859-B1 3-((4-ISOQUINOLIN-3-YL)METHYL)-1H-IMIDAZO[4,5-C]PYRIDIN-2(3H)-ONE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF REPLICATION OF THE RESPIRATORY SYNCYTIAL VIRUS (RSV) BOEHRINGER INGELHEIM INT (DE) 2020-06-03 — — EP disclosed
US-20190002436-A1 RESPIRATORY SYNCYTIAL VIRUS INHIBITORS MEDIVIR AB (SE) 2019-01-03 — — US disclosed
WO-2017018924-A1 RESPIRATORY SYNCYTIAL VIRUS INHIBITORS MEDIVIR AB (SE) 2017-02-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190002436-A1 RESPIRATORY SYNCYTIAL VIRUS INHIBITORS NR0B1, NR1I3, SCARB1 CYP11B1 272/4885CYP11B2 704/4885CYP1A2 779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback